Document Type

Article

Publication Date

January 2024

Patent Number

11857679

CPC

A61K 9/1075 , A61K 31/496 , A61K 47/20 , A61K 47/552 , A61K 47/58 , A61K 47/6907 , A61P 31/04 , Y02A 50/30

Abstract

The subject invention pertains to polyacrylate homopolymers produced from acrylolated drug monomers. The homopolymers can be produced in the form of nanoparticles. The nanoparticles comprising the homopolymers can be produced via a free radical-induced emulsion polymerization of the acrylolated drug monomers to produce an aqueous emulsion of uniformly sized nanoparticles. The homopolymers of the invention containing acrylolated antibiotic monomers can be active against Gram-positive and Gram-negative bacteria, such as Staphylococcus aureus and Escherichia coli. Accordingly, methods are provided of treating a disease, for example, an infection, by administering to a subject the homopolymers, homopolymeric nanoparticles, or emulsions containing homopolymeric nanoparticles of the invention.

Application Number

17/472819

Assignees

UNIVERSITY OF SOUTH FLORIDA

Filing Date

09/13/2021

Share

COinS